Loading page…

Report overview

The report highlights the company's philanthropic activity in 2019, including 25 grants totaling DKK 79 million and the inauguration and first research results of the Skin Immunology Research Center. It also reports that LEO Pharma revenue grew 4% to DKK 10,805 million. The CSR section describes UN Global Compact-based conduct, ESG screening of equity index investments and energy-saving action at LEO Pharma.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019
Period: 1 January 2019 – 31 December 2019
Publication date: 11 March 2020
Language
Pages
File size

Standards & Assurance

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Assurance

Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Employees
Women on the board
Women in management

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services